NASDAQ:CDIO Cardio Diagnostics Q3 2025 Earnings Report $1.74 +0.08 (+4.52%) As of 10:30 AM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast Cardio Diagnostics EPS ResultsActual EPS-$0.98Consensus EPS -$1.80Beat/MissBeat by +$0.82One Year Ago EPSN/ACardio Diagnostics Revenue ResultsActual Revenue$0.00 millionExpected Revenue$0.15 millionBeat/MissMissed by -$147.00 thousandYoY Revenue GrowthN/ACardio Diagnostics Announcement DetailsQuarterQ3 2025Date11/12/2025TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AUpcoming EarningsCardio Diagnostics' next earnings date is estimated for Thursday, August 13, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Cardio Diagnostics Earnings HeadlinesCardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026August 5 at 8:35 AM | businesswire.comCardio Diagnostics Hldgs Insider Trading Activity | NASDAQ:CDIO | BenzingaJuly 7, 2026 | benzinga.comIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.August 7 at 1:00 AM | Banyan Hill Publishing (Ad)Cardio Diagnostics Holdings (CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health PlansJuly 1, 2026 | finance.yahoo.comCardio Diagnostics Holdings (NASDAQ: CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health PlansJuly 1, 2026 | markets.businessinsider.comCardio Diagnostics Holdings (NASDAQ: CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease RisksJune 30, 2026 | markets.businessinsider.comSee More Cardio Diagnostics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Cardio Diagnostics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cardio Diagnostics and other key companies, straight to your email. Email Address About Cardio DiagnosticsCardio Diagnostics (NASDAQ:CDIO) develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.View Cardio Diagnostics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Boeing's Comeback Is Building Momentum—Is It Real?Sandisk Just Delivered a Blowout Quarter—Here's Why the Stock Is FallingWestern Digital Stock Falls 12% Despite Beating Earnings EstimatesBed Bath & Beyond Renovates: The Neighborhood BlueprintOne Comment on CVS's Earnings Call Sent the Stock TumblingSpaceX: Love the Company, But the Stock Is a Harder CallDisney Sets Up for a Magical Year in 2027 Upcoming Earnings Barrick Mining (8/10/2026)Simon Property Group (8/10/2026)SEA (8/11/2026)Cardinal Health (8/11/2026)Lumentum (8/11/2026)Cisco Systems (8/12/2026)Nebius Group (8/12/2026)NetEase (8/13/2026)Brookfield (8/13/2026)NU (8/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
